Patent Yard Sign in
Canadian application, no grantCanada

Genes encoding mlo proteins and conferring fungal resistance upon plants

CA 2322016 A1 · Owner: Novartis Ag · Inventors: Kramer, Catherine Mae; Strawn, Leslie Jean; Salmeron, John Manuel

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention describes genes encoding proteins which control resistance of plants to fungal pathogens. The invention also describes transgenic plants resistant to fungal pathogens and methods for making plants resistant to fungal pathogens. The invention further discloses a method to isolate additional genes coding for additional proteins controlling the resistance of plants to fungal pathogens.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 17, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 17, 1999
GrantedNo grant recorded
Term endedMarch 17, 2019
Patent numberCA 2322016 A1
Classification (IPC)A01H5/00 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedMarch 17, 1999Term endedMarch 17, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.